For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240904:nRSD7615Ca&default-theme=true
RNS Number : 7615C CLS Holdings PLC 04 September 2024
PRESS RELEASE
Release date: 4 September 2024
Embargoed until: 07:00 am
CLS Holdings plc ("CLS" or the "Group")
CLS leases over 8,900 sqm in Hamburg, Germany
CLS announces it has let 8,939 sqm (96,219 sq. ft) at Fangdieckstrasse 75 in
Hamburg to the Hamburg Institut für Pathologie und Hämatopathologie (HPH).
The HPH Institute, which specialises in the diagnosis of haematological
diseases, has extended its existing lease of 5,628 sqm (60,579 sq. ft) of
office and laboratory space until 2035 and has leased an additional 3,311 sqm
(35,639 sq. ft) of office and production space in the property. The HPH
Institute will move into the additional space from September 2024, following
the current occupier's lease surrender, meaning the property will remain fully
let.
Fangdieckstrasse 75 was acquired by CLS in 2007 and has since been fully
refurbished and successfully repositioned as a science and healthcare hub. The
multi-tenant property has 13,092 sqm (140,921 Sq. ft) and offers a mix of
office, light industrial, and laboratory space.
Located close to the 'Science City Hamburg Bahrenfeld' area of Hamburg,
occupied by science and technology start-ups, the property is well connected
to major transport links.
Fredrik Widlund, Chief Executive Officer of CLS, commented:
"We are thrilled that HPH has not only extended their existing lease for over
10 years but has also chosen to lease additional space in Fangdieckstrasse 75.
Hamburg-Bahrenfeld is an up-and-coming commercial area and CLS has
successfully repositioned the property as an attractive location for science
and technology organisations, and demand from occupiers in this sector remains
high."
-ENDS-
For further information, please contact:
CLS Holdings plc
(LEI: 213800A357TKB2TD9U78)
www.clsholdings.com (http://www.clsholdings.com)
Fredrik Widlund, Chief Executive Officer
Andrew Kirkman, Chief Financial Officer
+44 (0)20 7582 7766
Media Contact:
Edelman Smithfield (Financial PR)
Alex Simmons
+44 7970 174 353
Hastings Tarrant
+44 7813 407 665
cls@edelmansmithfield.com (mailto:cls@edelmansmithfield.com)
Broker Contacts:
Panmure Liberum
Jamie Richards
David Watkins
+44 (0)20 3100 2000
Berenberg
Matthew Armitt
Richard Bootle
+44 (0) 203 207 7800
Registered in England No. 2714781. Registered Office as above
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCUOUVRSAUKRAR